Hall Ashley
Insider CIK 1801842 · ESPR Chief Development Officer · RPHM Chief Development Officer · GPCR Chief Development Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics Inc | A Award deriv | 2026-03-19 | 2026-03-23 | 59,073 | — | $0 | 59,073 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award | 2026-03-19 | 2026-03-23 | 47,706 | — | $0 | 155,187 | SEC↗ |
| GPCR Structure Therapeutics Inc | F Tax w/h | 2026-03-03 | 2026-03-05 | 4,836 | $20.99 | $101.5K | 107,481 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award deriv | 2025-11-20 | 2026-03-05 | 237 | — | $0 | 462 | SEC↗ |
| GPCR Structure Therapeutics Inc | F Tax w/h | 2025-09-18 | 2025-09-22 | 6,021 | $7.74 | $46.6K | 112,317 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award deriv | 2025-05-20 | 2026-03-05 | 225 | — | $0 | 225 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award deriv | 2025-03-15 | 2025-03-18 | 124,032 | — | $0 | 124,032 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award | 2025-03-15 | 2025-03-18 | 51,048 | — | $0 | 118,338 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award deriv | 2024-09-18 | 2024-09-20 | 82,890 | — | $0 | 82,890 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award | 2024-09-18 | 2024-09-20 | 67,290 | — | $0 | 67,290 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | M Exercise deriv | 2023-08-28 | 2023-08-29 | 15,625 | — | $0 | 109,375 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | M Exercise | 2023-08-28 | 2023-08-29 | 15,625 | $1.80 | $28.1K | 55,225 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | S Sale | 2023-08-28 | 2023-08-29 | 15,625 | $6.28 | $98.1K | 39,600 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | A Award deriv | 2022-12-09 | 2022-12-13 | 125,000 | — | $0 | 125,000 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | A Award deriv | 2021-11-12 | 2021-11-15 | 180,000 | — | $0 | 180,000 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | A Award | 2021-11-12 | 2021-11-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2021-01-28 | 2021-01-29 | 31,000 | — | $0 | 31,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2021-01-28 | 2021-01-29 | 7,000 | — | $0 | 22,500 | SEC↗ |